A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors.
Misako NagasakaNadine H AbdallahMarcus CrosbyNithin ThummalaDhaval PatelAntoinette J WozniakShirish GadgeelJudith AbramsAmmar SukariPublished in: Lung Cancer (Auckland, N.Z.) (2019)
PTV in NSCLC did not prove to be a predictor of response to PD-1 inhibitors but having liver metastasis was associated with significantly shorter survival.